Research ArticleArticle
Determining a Magnetic Resonance Imaging Inflammatory Activity Acceptable State Without Subsequent Radiographic Progression in Rheumatoid Arthritis: Results from a Followup MRI Study of 254 Patients in Clinical Remission or Low Disease Activity
Frédérique Gandjbakhch, Espen A. Haavardsholm, Philip G. Conaghan, Bo Ejbjerg, Violaine Foltz, Andrew K. Brown, Uffe Møller Døhn, Marissa Lassere, Jane E. Freeston, Inge Christoffer Olsen, Pernille Bøyesen, Paul Bird, Bruno Fautrel, Merete Lund Hetland, Paul Emery, Pierre Bourgeois, Kim Hørslev-Petersen, Tore K. Kvien, Fiona M. McQueen and Mikkel Østergaard
The Journal of Rheumatology December 2013, jrheum.131088; DOI: https://doi.org/10.3899/jrheum.131088
Frédérique Gandjbakhch
From the Department of Rheumatology, Pitie Salpetriere Hospital, APHP, Université Paris 6-UPMC, Paris, France; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Department of Rheumatology, Slagelse Hospital, Slagelse, Denmark; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Hull York Medical School, University of York, York, UK; Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Glostrup Hospital, Copenhagen, Denmark; and Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; St. George Hospital, University of NSW, Sydney, Australia; King Christian X’s Hospital for Rheumatic Diseases, University of Southern Denmark, Odense, Denmark; and Department of Molecular Medicine and Pathology, Faculty of Medicine and Health Sciences, University of Auckland, Auckland, New Zealand. Dr. Conaghan has been a speaker or on advisory boards for BMS, Janssen, Merck, Pfizer, and Roche. F. Gandjbakhch, MD, Practicing Rheumatologist, Department of Rheumatology, Pitie Salpetriere Hospital, APHP, Université Paris 6-UPMC; E.A. Haavardsholm, MD, PhD, Postdoctoral Researcher, Department of Rheumatology, Diakonhjemmet Hospital; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Professor of Musculoskeletal Medicine, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit; B. Ejbjerg, MD, PhD, Consultant Rheumatologist, Department of Rheumatology, Slagelse Hospital; V. Foltz, MD, Practicing Rheumatologist, Department of Rheumatology, Pitie Salpetriere Hospital, APHP, Université Paris 6-UPMC; A.K. Brown, MB, ChB, MRCP, PhD, Hull York Medical School, University of York; U.M. Døhn, MD, PhD, Senior/Registrar, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Glostrup; M. Lassere, MBBS(Hons), PhD, Grad Dip Epi, FRACP, FAFPHM, Professor of Medicine, St. George Hospital, University of NSW; J.E. Freeston, MA, MD, MRCP, Senior Lecturer and Honorary Consultant Rheumatologist, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit; I.C. Olsen, PhD, Biostatistician, Department of Rheumatology, Diakonhjemmet Hospital; P. Bøyesen, MD, PhD, Senior Registrar, Department of Rheumatology, Diakonhjemmet Hospital; P. Bird, BMed (Hons), FRACP, PhD, Grad Dip MRI, Senior Lecturer, University of NSW; B. Fautrel, MD, PhD, Associate Professor in Medicine, Department of Rheumatology, Pitie Salpetriere Hospital, APHP, Université Paris 6-UPMC; M.L. Hetland, MD, PhD, DMSc, Consultant and Senior Lecturer in Rheumatology, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Glostrup Hospital, and Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen; P. Emery, MA, MD, FRCP, ARC Professor in Rheumatology, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit. Drs. Gandjbakhch and Haavardsholm contributed equally to this work. Address correspondence to Dr. Haavardsholm, Diakonhjemmet Hospital, Box 23 Vindern, 0319 Oslo, Norway; E-mail: e.a.haavardsholm@medisin.uio.no.
Espen A. Haavardsholm
From the Department of Rheumatology, Pitie Salpetriere Hospital, APHP, Université Paris 6-UPMC, Paris, France; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Department of Rheumatology, Slagelse Hospital, Slagelse, Denmark; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Hull York Medical School, University of York, York, UK; Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Glostrup Hospital, Copenhagen, Denmark; and Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; St. George Hospital, University of NSW, Sydney, Australia; King Christian X’s Hospital for Rheumatic Diseases, University of Southern Denmark, Odense, Denmark; and Department of Molecular Medicine and Pathology, Faculty of Medicine and Health Sciences, University of Auckland, Auckland, New Zealand. Dr. Conaghan has been a speaker or on advisory boards for BMS, Janssen, Merck, Pfizer, and Roche. F. Gandjbakhch, MD, Practicing Rheumatologist, Department of Rheumatology, Pitie Salpetriere Hospital, APHP, Université Paris 6-UPMC; E.A. Haavardsholm, MD, PhD, Postdoctoral Researcher, Department of Rheumatology, Diakonhjemmet Hospital; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Professor of Musculoskeletal Medicine, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit; B. Ejbjerg, MD, PhD, Consultant Rheumatologist, Department of Rheumatology, Slagelse Hospital; V. Foltz, MD, Practicing Rheumatologist, Department of Rheumatology, Pitie Salpetriere Hospital, APHP, Université Paris 6-UPMC; A.K. Brown, MB, ChB, MRCP, PhD, Hull York Medical School, University of York; U.M. Døhn, MD, PhD, Senior/Registrar, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Glostrup; M. Lassere, MBBS(Hons), PhD, Grad Dip Epi, FRACP, FAFPHM, Professor of Medicine, St. George Hospital, University of NSW; J.E. Freeston, MA, MD, MRCP, Senior Lecturer and Honorary Consultant Rheumatologist, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit; I.C. Olsen, PhD, Biostatistician, Department of Rheumatology, Diakonhjemmet Hospital; P. Bøyesen, MD, PhD, Senior Registrar, Department of Rheumatology, Diakonhjemmet Hospital; P. Bird, BMed (Hons), FRACP, PhD, Grad Dip MRI, Senior Lecturer, University of NSW; B. Fautrel, MD, PhD, Associate Professor in Medicine, Department of Rheumatology, Pitie Salpetriere Hospital, APHP, Université Paris 6-UPMC; M.L. Hetland, MD, PhD, DMSc, Consultant and Senior Lecturer in Rheumatology, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Glostrup Hospital, and Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen; P. Emery, MA, MD, FRCP, ARC Professor in Rheumatology, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit. Drs. Gandjbakhch and Haavardsholm contributed equally to this work. Address correspondence to Dr. Haavardsholm, Diakonhjemmet Hospital, Box 23 Vindern, 0319 Oslo, Norway; E-mail: e.a.haavardsholm@medisin.uio.no.
Philip G. Conaghan
From the Department of Rheumatology, Pitie Salpetriere Hospital, APHP, Université Paris 6-UPMC, Paris, France; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Department of Rheumatology, Slagelse Hospital, Slagelse, Denmark; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Hull York Medical School, University of York, York, UK; Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Glostrup Hospital, Copenhagen, Denmark; and Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; St. George Hospital, University of NSW, Sydney, Australia; King Christian X’s Hospital for Rheumatic Diseases, University of Southern Denmark, Odense, Denmark; and Department of Molecular Medicine and Pathology, Faculty of Medicine and Health Sciences, University of Auckland, Auckland, New Zealand. Dr. Conaghan has been a speaker or on advisory boards for BMS, Janssen, Merck, Pfizer, and Roche. F. Gandjbakhch, MD, Practicing Rheumatologist, Department of Rheumatology, Pitie Salpetriere Hospital, APHP, Université Paris 6-UPMC; E.A. Haavardsholm, MD, PhD, Postdoctoral Researcher, Department of Rheumatology, Diakonhjemmet Hospital; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Professor of Musculoskeletal Medicine, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit; B. Ejbjerg, MD, PhD, Consultant Rheumatologist, Department of Rheumatology, Slagelse Hospital; V. Foltz, MD, Practicing Rheumatologist, Department of Rheumatology, Pitie Salpetriere Hospital, APHP, Université Paris 6-UPMC; A.K. Brown, MB, ChB, MRCP, PhD, Hull York Medical School, University of York; U.M. Døhn, MD, PhD, Senior/Registrar, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Glostrup; M. Lassere, MBBS(Hons), PhD, Grad Dip Epi, FRACP, FAFPHM, Professor of Medicine, St. George Hospital, University of NSW; J.E. Freeston, MA, MD, MRCP, Senior Lecturer and Honorary Consultant Rheumatologist, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit; I.C. Olsen, PhD, Biostatistician, Department of Rheumatology, Diakonhjemmet Hospital; P. Bøyesen, MD, PhD, Senior Registrar, Department of Rheumatology, Diakonhjemmet Hospital; P. Bird, BMed (Hons), FRACP, PhD, Grad Dip MRI, Senior Lecturer, University of NSW; B. Fautrel, MD, PhD, Associate Professor in Medicine, Department of Rheumatology, Pitie Salpetriere Hospital, APHP, Université Paris 6-UPMC; M.L. Hetland, MD, PhD, DMSc, Consultant and Senior Lecturer in Rheumatology, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Glostrup Hospital, and Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen; P. Emery, MA, MD, FRCP, ARC Professor in Rheumatology, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit. Drs. Gandjbakhch and Haavardsholm contributed equally to this work. Address correspondence to Dr. Haavardsholm, Diakonhjemmet Hospital, Box 23 Vindern, 0319 Oslo, Norway; E-mail: e.a.haavardsholm@medisin.uio.no.
Bo Ejbjerg
From the Department of Rheumatology, Pitie Salpetriere Hospital, APHP, Université Paris 6-UPMC, Paris, France; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Department of Rheumatology, Slagelse Hospital, Slagelse, Denmark; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Hull York Medical School, University of York, York, UK; Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Glostrup Hospital, Copenhagen, Denmark; and Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; St. George Hospital, University of NSW, Sydney, Australia; King Christian X’s Hospital for Rheumatic Diseases, University of Southern Denmark, Odense, Denmark; and Department of Molecular Medicine and Pathology, Faculty of Medicine and Health Sciences, University of Auckland, Auckland, New Zealand. Dr. Conaghan has been a speaker or on advisory boards for BMS, Janssen, Merck, Pfizer, and Roche. F. Gandjbakhch, MD, Practicing Rheumatologist, Department of Rheumatology, Pitie Salpetriere Hospital, APHP, Université Paris 6-UPMC; E.A. Haavardsholm, MD, PhD, Postdoctoral Researcher, Department of Rheumatology, Diakonhjemmet Hospital; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Professor of Musculoskeletal Medicine, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit; B. Ejbjerg, MD, PhD, Consultant Rheumatologist, Department of Rheumatology, Slagelse Hospital; V. Foltz, MD, Practicing Rheumatologist, Department of Rheumatology, Pitie Salpetriere Hospital, APHP, Université Paris 6-UPMC; A.K. Brown, MB, ChB, MRCP, PhD, Hull York Medical School, University of York; U.M. Døhn, MD, PhD, Senior/Registrar, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Glostrup; M. Lassere, MBBS(Hons), PhD, Grad Dip Epi, FRACP, FAFPHM, Professor of Medicine, St. George Hospital, University of NSW; J.E. Freeston, MA, MD, MRCP, Senior Lecturer and Honorary Consultant Rheumatologist, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit; I.C. Olsen, PhD, Biostatistician, Department of Rheumatology, Diakonhjemmet Hospital; P. Bøyesen, MD, PhD, Senior Registrar, Department of Rheumatology, Diakonhjemmet Hospital; P. Bird, BMed (Hons), FRACP, PhD, Grad Dip MRI, Senior Lecturer, University of NSW; B. Fautrel, MD, PhD, Associate Professor in Medicine, Department of Rheumatology, Pitie Salpetriere Hospital, APHP, Université Paris 6-UPMC; M.L. Hetland, MD, PhD, DMSc, Consultant and Senior Lecturer in Rheumatology, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Glostrup Hospital, and Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen; P. Emery, MA, MD, FRCP, ARC Professor in Rheumatology, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit. Drs. Gandjbakhch and Haavardsholm contributed equally to this work. Address correspondence to Dr. Haavardsholm, Diakonhjemmet Hospital, Box 23 Vindern, 0319 Oslo, Norway; E-mail: e.a.haavardsholm@medisin.uio.no.
Violaine Foltz
From the Department of Rheumatology, Pitie Salpetriere Hospital, APHP, Université Paris 6-UPMC, Paris, France; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Department of Rheumatology, Slagelse Hospital, Slagelse, Denmark; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Hull York Medical School, University of York, York, UK; Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Glostrup Hospital, Copenhagen, Denmark; and Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; St. George Hospital, University of NSW, Sydney, Australia; King Christian X’s Hospital for Rheumatic Diseases, University of Southern Denmark, Odense, Denmark; and Department of Molecular Medicine and Pathology, Faculty of Medicine and Health Sciences, University of Auckland, Auckland, New Zealand. Dr. Conaghan has been a speaker or on advisory boards for BMS, Janssen, Merck, Pfizer, and Roche. F. Gandjbakhch, MD, Practicing Rheumatologist, Department of Rheumatology, Pitie Salpetriere Hospital, APHP, Université Paris 6-UPMC; E.A. Haavardsholm, MD, PhD, Postdoctoral Researcher, Department of Rheumatology, Diakonhjemmet Hospital; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Professor of Musculoskeletal Medicine, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit; B. Ejbjerg, MD, PhD, Consultant Rheumatologist, Department of Rheumatology, Slagelse Hospital; V. Foltz, MD, Practicing Rheumatologist, Department of Rheumatology, Pitie Salpetriere Hospital, APHP, Université Paris 6-UPMC; A.K. Brown, MB, ChB, MRCP, PhD, Hull York Medical School, University of York; U.M. Døhn, MD, PhD, Senior/Registrar, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Glostrup; M. Lassere, MBBS(Hons), PhD, Grad Dip Epi, FRACP, FAFPHM, Professor of Medicine, St. George Hospital, University of NSW; J.E. Freeston, MA, MD, MRCP, Senior Lecturer and Honorary Consultant Rheumatologist, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit; I.C. Olsen, PhD, Biostatistician, Department of Rheumatology, Diakonhjemmet Hospital; P. Bøyesen, MD, PhD, Senior Registrar, Department of Rheumatology, Diakonhjemmet Hospital; P. Bird, BMed (Hons), FRACP, PhD, Grad Dip MRI, Senior Lecturer, University of NSW; B. Fautrel, MD, PhD, Associate Professor in Medicine, Department of Rheumatology, Pitie Salpetriere Hospital, APHP, Université Paris 6-UPMC; M.L. Hetland, MD, PhD, DMSc, Consultant and Senior Lecturer in Rheumatology, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Glostrup Hospital, and Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen; P. Emery, MA, MD, FRCP, ARC Professor in Rheumatology, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit. Drs. Gandjbakhch and Haavardsholm contributed equally to this work. Address correspondence to Dr. Haavardsholm, Diakonhjemmet Hospital, Box 23 Vindern, 0319 Oslo, Norway; E-mail: e.a.haavardsholm@medisin.uio.no.
Andrew K. Brown
From the Department of Rheumatology, Pitie Salpetriere Hospital, APHP, Université Paris 6-UPMC, Paris, France; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Department of Rheumatology, Slagelse Hospital, Slagelse, Denmark; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Hull York Medical School, University of York, York, UK; Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Glostrup Hospital, Copenhagen, Denmark; and Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; St. George Hospital, University of NSW, Sydney, Australia; King Christian X’s Hospital for Rheumatic Diseases, University of Southern Denmark, Odense, Denmark; and Department of Molecular Medicine and Pathology, Faculty of Medicine and Health Sciences, University of Auckland, Auckland, New Zealand. Dr. Conaghan has been a speaker or on advisory boards for BMS, Janssen, Merck, Pfizer, and Roche. F. Gandjbakhch, MD, Practicing Rheumatologist, Department of Rheumatology, Pitie Salpetriere Hospital, APHP, Université Paris 6-UPMC; E.A. Haavardsholm, MD, PhD, Postdoctoral Researcher, Department of Rheumatology, Diakonhjemmet Hospital; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Professor of Musculoskeletal Medicine, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit; B. Ejbjerg, MD, PhD, Consultant Rheumatologist, Department of Rheumatology, Slagelse Hospital; V. Foltz, MD, Practicing Rheumatologist, Department of Rheumatology, Pitie Salpetriere Hospital, APHP, Université Paris 6-UPMC; A.K. Brown, MB, ChB, MRCP, PhD, Hull York Medical School, University of York; U.M. Døhn, MD, PhD, Senior/Registrar, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Glostrup; M. Lassere, MBBS(Hons), PhD, Grad Dip Epi, FRACP, FAFPHM, Professor of Medicine, St. George Hospital, University of NSW; J.E. Freeston, MA, MD, MRCP, Senior Lecturer and Honorary Consultant Rheumatologist, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit; I.C. Olsen, PhD, Biostatistician, Department of Rheumatology, Diakonhjemmet Hospital; P. Bøyesen, MD, PhD, Senior Registrar, Department of Rheumatology, Diakonhjemmet Hospital; P. Bird, BMed (Hons), FRACP, PhD, Grad Dip MRI, Senior Lecturer, University of NSW; B. Fautrel, MD, PhD, Associate Professor in Medicine, Department of Rheumatology, Pitie Salpetriere Hospital, APHP, Université Paris 6-UPMC; M.L. Hetland, MD, PhD, DMSc, Consultant and Senior Lecturer in Rheumatology, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Glostrup Hospital, and Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen; P. Emery, MA, MD, FRCP, ARC Professor in Rheumatology, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit. Drs. Gandjbakhch and Haavardsholm contributed equally to this work. Address correspondence to Dr. Haavardsholm, Diakonhjemmet Hospital, Box 23 Vindern, 0319 Oslo, Norway; E-mail: e.a.haavardsholm@medisin.uio.no.
Uffe Møller Døhn
From the Department of Rheumatology, Pitie Salpetriere Hospital, APHP, Université Paris 6-UPMC, Paris, France; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Department of Rheumatology, Slagelse Hospital, Slagelse, Denmark; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Hull York Medical School, University of York, York, UK; Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Glostrup Hospital, Copenhagen, Denmark; and Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; St. George Hospital, University of NSW, Sydney, Australia; King Christian X’s Hospital for Rheumatic Diseases, University of Southern Denmark, Odense, Denmark; and Department of Molecular Medicine and Pathology, Faculty of Medicine and Health Sciences, University of Auckland, Auckland, New Zealand. Dr. Conaghan has been a speaker or on advisory boards for BMS, Janssen, Merck, Pfizer, and Roche. F. Gandjbakhch, MD, Practicing Rheumatologist, Department of Rheumatology, Pitie Salpetriere Hospital, APHP, Université Paris 6-UPMC; E.A. Haavardsholm, MD, PhD, Postdoctoral Researcher, Department of Rheumatology, Diakonhjemmet Hospital; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Professor of Musculoskeletal Medicine, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit; B. Ejbjerg, MD, PhD, Consultant Rheumatologist, Department of Rheumatology, Slagelse Hospital; V. Foltz, MD, Practicing Rheumatologist, Department of Rheumatology, Pitie Salpetriere Hospital, APHP, Université Paris 6-UPMC; A.K. Brown, MB, ChB, MRCP, PhD, Hull York Medical School, University of York; U.M. Døhn, MD, PhD, Senior/Registrar, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Glostrup; M. Lassere, MBBS(Hons), PhD, Grad Dip Epi, FRACP, FAFPHM, Professor of Medicine, St. George Hospital, University of NSW; J.E. Freeston, MA, MD, MRCP, Senior Lecturer and Honorary Consultant Rheumatologist, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit; I.C. Olsen, PhD, Biostatistician, Department of Rheumatology, Diakonhjemmet Hospital; P. Bøyesen, MD, PhD, Senior Registrar, Department of Rheumatology, Diakonhjemmet Hospital; P. Bird, BMed (Hons), FRACP, PhD, Grad Dip MRI, Senior Lecturer, University of NSW; B. Fautrel, MD, PhD, Associate Professor in Medicine, Department of Rheumatology, Pitie Salpetriere Hospital, APHP, Université Paris 6-UPMC; M.L. Hetland, MD, PhD, DMSc, Consultant and Senior Lecturer in Rheumatology, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Glostrup Hospital, and Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen; P. Emery, MA, MD, FRCP, ARC Professor in Rheumatology, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit. Drs. Gandjbakhch and Haavardsholm contributed equally to this work. Address correspondence to Dr. Haavardsholm, Diakonhjemmet Hospital, Box 23 Vindern, 0319 Oslo, Norway; E-mail: e.a.haavardsholm@medisin.uio.no.
Marissa Lassere
From the Department of Rheumatology, Pitie Salpetriere Hospital, APHP, Université Paris 6-UPMC, Paris, France; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Department of Rheumatology, Slagelse Hospital, Slagelse, Denmark; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Hull York Medical School, University of York, York, UK; Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Glostrup Hospital, Copenhagen, Denmark; and Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; St. George Hospital, University of NSW, Sydney, Australia; King Christian X’s Hospital for Rheumatic Diseases, University of Southern Denmark, Odense, Denmark; and Department of Molecular Medicine and Pathology, Faculty of Medicine and Health Sciences, University of Auckland, Auckland, New Zealand. Dr. Conaghan has been a speaker or on advisory boards for BMS, Janssen, Merck, Pfizer, and Roche. F. Gandjbakhch, MD, Practicing Rheumatologist, Department of Rheumatology, Pitie Salpetriere Hospital, APHP, Université Paris 6-UPMC; E.A. Haavardsholm, MD, PhD, Postdoctoral Researcher, Department of Rheumatology, Diakonhjemmet Hospital; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Professor of Musculoskeletal Medicine, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit; B. Ejbjerg, MD, PhD, Consultant Rheumatologist, Department of Rheumatology, Slagelse Hospital; V. Foltz, MD, Practicing Rheumatologist, Department of Rheumatology, Pitie Salpetriere Hospital, APHP, Université Paris 6-UPMC; A.K. Brown, MB, ChB, MRCP, PhD, Hull York Medical School, University of York; U.M. Døhn, MD, PhD, Senior/Registrar, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Glostrup; M. Lassere, MBBS(Hons), PhD, Grad Dip Epi, FRACP, FAFPHM, Professor of Medicine, St. George Hospital, University of NSW; J.E. Freeston, MA, MD, MRCP, Senior Lecturer and Honorary Consultant Rheumatologist, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit; I.C. Olsen, PhD, Biostatistician, Department of Rheumatology, Diakonhjemmet Hospital; P. Bøyesen, MD, PhD, Senior Registrar, Department of Rheumatology, Diakonhjemmet Hospital; P. Bird, BMed (Hons), FRACP, PhD, Grad Dip MRI, Senior Lecturer, University of NSW; B. Fautrel, MD, PhD, Associate Professor in Medicine, Department of Rheumatology, Pitie Salpetriere Hospital, APHP, Université Paris 6-UPMC; M.L. Hetland, MD, PhD, DMSc, Consultant and Senior Lecturer in Rheumatology, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Glostrup Hospital, and Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen; P. Emery, MA, MD, FRCP, ARC Professor in Rheumatology, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit. Drs. Gandjbakhch and Haavardsholm contributed equally to this work. Address correspondence to Dr. Haavardsholm, Diakonhjemmet Hospital, Box 23 Vindern, 0319 Oslo, Norway; E-mail: e.a.haavardsholm@medisin.uio.no.
Jane E. Freeston
From the Department of Rheumatology, Pitie Salpetriere Hospital, APHP, Université Paris 6-UPMC, Paris, France; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Department of Rheumatology, Slagelse Hospital, Slagelse, Denmark; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Hull York Medical School, University of York, York, UK; Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Glostrup Hospital, Copenhagen, Denmark; and Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; St. George Hospital, University of NSW, Sydney, Australia; King Christian X’s Hospital for Rheumatic Diseases, University of Southern Denmark, Odense, Denmark; and Department of Molecular Medicine and Pathology, Faculty of Medicine and Health Sciences, University of Auckland, Auckland, New Zealand. Dr. Conaghan has been a speaker or on advisory boards for BMS, Janssen, Merck, Pfizer, and Roche. F. Gandjbakhch, MD, Practicing Rheumatologist, Department of Rheumatology, Pitie Salpetriere Hospital, APHP, Université Paris 6-UPMC; E.A. Haavardsholm, MD, PhD, Postdoctoral Researcher, Department of Rheumatology, Diakonhjemmet Hospital; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Professor of Musculoskeletal Medicine, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit; B. Ejbjerg, MD, PhD, Consultant Rheumatologist, Department of Rheumatology, Slagelse Hospital; V. Foltz, MD, Practicing Rheumatologist, Department of Rheumatology, Pitie Salpetriere Hospital, APHP, Université Paris 6-UPMC; A.K. Brown, MB, ChB, MRCP, PhD, Hull York Medical School, University of York; U.M. Døhn, MD, PhD, Senior/Registrar, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Glostrup; M. Lassere, MBBS(Hons), PhD, Grad Dip Epi, FRACP, FAFPHM, Professor of Medicine, St. George Hospital, University of NSW; J.E. Freeston, MA, MD, MRCP, Senior Lecturer and Honorary Consultant Rheumatologist, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit; I.C. Olsen, PhD, Biostatistician, Department of Rheumatology, Diakonhjemmet Hospital; P. Bøyesen, MD, PhD, Senior Registrar, Department of Rheumatology, Diakonhjemmet Hospital; P. Bird, BMed (Hons), FRACP, PhD, Grad Dip MRI, Senior Lecturer, University of NSW; B. Fautrel, MD, PhD, Associate Professor in Medicine, Department of Rheumatology, Pitie Salpetriere Hospital, APHP, Université Paris 6-UPMC; M.L. Hetland, MD, PhD, DMSc, Consultant and Senior Lecturer in Rheumatology, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Glostrup Hospital, and Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen; P. Emery, MA, MD, FRCP, ARC Professor in Rheumatology, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit. Drs. Gandjbakhch and Haavardsholm contributed equally to this work. Address correspondence to Dr. Haavardsholm, Diakonhjemmet Hospital, Box 23 Vindern, 0319 Oslo, Norway; E-mail: e.a.haavardsholm@medisin.uio.no.
Inge Christoffer Olsen
From the Department of Rheumatology, Pitie Salpetriere Hospital, APHP, Université Paris 6-UPMC, Paris, France; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Department of Rheumatology, Slagelse Hospital, Slagelse, Denmark; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Hull York Medical School, University of York, York, UK; Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Glostrup Hospital, Copenhagen, Denmark; and Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; St. George Hospital, University of NSW, Sydney, Australia; King Christian X’s Hospital for Rheumatic Diseases, University of Southern Denmark, Odense, Denmark; and Department of Molecular Medicine and Pathology, Faculty of Medicine and Health Sciences, University of Auckland, Auckland, New Zealand. Dr. Conaghan has been a speaker or on advisory boards for BMS, Janssen, Merck, Pfizer, and Roche. F. Gandjbakhch, MD, Practicing Rheumatologist, Department of Rheumatology, Pitie Salpetriere Hospital, APHP, Université Paris 6-UPMC; E.A. Haavardsholm, MD, PhD, Postdoctoral Researcher, Department of Rheumatology, Diakonhjemmet Hospital; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Professor of Musculoskeletal Medicine, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit; B. Ejbjerg, MD, PhD, Consultant Rheumatologist, Department of Rheumatology, Slagelse Hospital; V. Foltz, MD, Practicing Rheumatologist, Department of Rheumatology, Pitie Salpetriere Hospital, APHP, Université Paris 6-UPMC; A.K. Brown, MB, ChB, MRCP, PhD, Hull York Medical School, University of York; U.M. Døhn, MD, PhD, Senior/Registrar, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Glostrup; M. Lassere, MBBS(Hons), PhD, Grad Dip Epi, FRACP, FAFPHM, Professor of Medicine, St. George Hospital, University of NSW; J.E. Freeston, MA, MD, MRCP, Senior Lecturer and Honorary Consultant Rheumatologist, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit; I.C. Olsen, PhD, Biostatistician, Department of Rheumatology, Diakonhjemmet Hospital; P. Bøyesen, MD, PhD, Senior Registrar, Department of Rheumatology, Diakonhjemmet Hospital; P. Bird, BMed (Hons), FRACP, PhD, Grad Dip MRI, Senior Lecturer, University of NSW; B. Fautrel, MD, PhD, Associate Professor in Medicine, Department of Rheumatology, Pitie Salpetriere Hospital, APHP, Université Paris 6-UPMC; M.L. Hetland, MD, PhD, DMSc, Consultant and Senior Lecturer in Rheumatology, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Glostrup Hospital, and Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen; P. Emery, MA, MD, FRCP, ARC Professor in Rheumatology, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit. Drs. Gandjbakhch and Haavardsholm contributed equally to this work. Address correspondence to Dr. Haavardsholm, Diakonhjemmet Hospital, Box 23 Vindern, 0319 Oslo, Norway; E-mail: e.a.haavardsholm@medisin.uio.no.
Pernille Bøyesen
From the Department of Rheumatology, Pitie Salpetriere Hospital, APHP, Université Paris 6-UPMC, Paris, France; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Department of Rheumatology, Slagelse Hospital, Slagelse, Denmark; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Hull York Medical School, University of York, York, UK; Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Glostrup Hospital, Copenhagen, Denmark; and Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; St. George Hospital, University of NSW, Sydney, Australia; King Christian X’s Hospital for Rheumatic Diseases, University of Southern Denmark, Odense, Denmark; and Department of Molecular Medicine and Pathology, Faculty of Medicine and Health Sciences, University of Auckland, Auckland, New Zealand. Dr. Conaghan has been a speaker or on advisory boards for BMS, Janssen, Merck, Pfizer, and Roche. F. Gandjbakhch, MD, Practicing Rheumatologist, Department of Rheumatology, Pitie Salpetriere Hospital, APHP, Université Paris 6-UPMC; E.A. Haavardsholm, MD, PhD, Postdoctoral Researcher, Department of Rheumatology, Diakonhjemmet Hospital; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Professor of Musculoskeletal Medicine, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit; B. Ejbjerg, MD, PhD, Consultant Rheumatologist, Department of Rheumatology, Slagelse Hospital; V. Foltz, MD, Practicing Rheumatologist, Department of Rheumatology, Pitie Salpetriere Hospital, APHP, Université Paris 6-UPMC; A.K. Brown, MB, ChB, MRCP, PhD, Hull York Medical School, University of York; U.M. Døhn, MD, PhD, Senior/Registrar, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Glostrup; M. Lassere, MBBS(Hons), PhD, Grad Dip Epi, FRACP, FAFPHM, Professor of Medicine, St. George Hospital, University of NSW; J.E. Freeston, MA, MD, MRCP, Senior Lecturer and Honorary Consultant Rheumatologist, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit; I.C. Olsen, PhD, Biostatistician, Department of Rheumatology, Diakonhjemmet Hospital; P. Bøyesen, MD, PhD, Senior Registrar, Department of Rheumatology, Diakonhjemmet Hospital; P. Bird, BMed (Hons), FRACP, PhD, Grad Dip MRI, Senior Lecturer, University of NSW; B. Fautrel, MD, PhD, Associate Professor in Medicine, Department of Rheumatology, Pitie Salpetriere Hospital, APHP, Université Paris 6-UPMC; M.L. Hetland, MD, PhD, DMSc, Consultant and Senior Lecturer in Rheumatology, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Glostrup Hospital, and Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen; P. Emery, MA, MD, FRCP, ARC Professor in Rheumatology, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit. Drs. Gandjbakhch and Haavardsholm contributed equally to this work. Address correspondence to Dr. Haavardsholm, Diakonhjemmet Hospital, Box 23 Vindern, 0319 Oslo, Norway; E-mail: e.a.haavardsholm@medisin.uio.no.
Paul Bird
From the Department of Rheumatology, Pitie Salpetriere Hospital, APHP, Université Paris 6-UPMC, Paris, France; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Department of Rheumatology, Slagelse Hospital, Slagelse, Denmark; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Hull York Medical School, University of York, York, UK; Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Glostrup Hospital, Copenhagen, Denmark; and Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; St. George Hospital, University of NSW, Sydney, Australia; King Christian X’s Hospital for Rheumatic Diseases, University of Southern Denmark, Odense, Denmark; and Department of Molecular Medicine and Pathology, Faculty of Medicine and Health Sciences, University of Auckland, Auckland, New Zealand. Dr. Conaghan has been a speaker or on advisory boards for BMS, Janssen, Merck, Pfizer, and Roche. F. Gandjbakhch, MD, Practicing Rheumatologist, Department of Rheumatology, Pitie Salpetriere Hospital, APHP, Université Paris 6-UPMC; E.A. Haavardsholm, MD, PhD, Postdoctoral Researcher, Department of Rheumatology, Diakonhjemmet Hospital; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Professor of Musculoskeletal Medicine, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit; B. Ejbjerg, MD, PhD, Consultant Rheumatologist, Department of Rheumatology, Slagelse Hospital; V. Foltz, MD, Practicing Rheumatologist, Department of Rheumatology, Pitie Salpetriere Hospital, APHP, Université Paris 6-UPMC; A.K. Brown, MB, ChB, MRCP, PhD, Hull York Medical School, University of York; U.M. Døhn, MD, PhD, Senior/Registrar, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Glostrup; M. Lassere, MBBS(Hons), PhD, Grad Dip Epi, FRACP, FAFPHM, Professor of Medicine, St. George Hospital, University of NSW; J.E. Freeston, MA, MD, MRCP, Senior Lecturer and Honorary Consultant Rheumatologist, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit; I.C. Olsen, PhD, Biostatistician, Department of Rheumatology, Diakonhjemmet Hospital; P. Bøyesen, MD, PhD, Senior Registrar, Department of Rheumatology, Diakonhjemmet Hospital; P. Bird, BMed (Hons), FRACP, PhD, Grad Dip MRI, Senior Lecturer, University of NSW; B. Fautrel, MD, PhD, Associate Professor in Medicine, Department of Rheumatology, Pitie Salpetriere Hospital, APHP, Université Paris 6-UPMC; M.L. Hetland, MD, PhD, DMSc, Consultant and Senior Lecturer in Rheumatology, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Glostrup Hospital, and Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen; P. Emery, MA, MD, FRCP, ARC Professor in Rheumatology, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit. Drs. Gandjbakhch and Haavardsholm contributed equally to this work. Address correspondence to Dr. Haavardsholm, Diakonhjemmet Hospital, Box 23 Vindern, 0319 Oslo, Norway; E-mail: e.a.haavardsholm@medisin.uio.no.
Bruno Fautrel
From the Department of Rheumatology, Pitie Salpetriere Hospital, APHP, Université Paris 6-UPMC, Paris, France; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Department of Rheumatology, Slagelse Hospital, Slagelse, Denmark; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Hull York Medical School, University of York, York, UK; Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Glostrup Hospital, Copenhagen, Denmark; and Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; St. George Hospital, University of NSW, Sydney, Australia; King Christian X’s Hospital for Rheumatic Diseases, University of Southern Denmark, Odense, Denmark; and Department of Molecular Medicine and Pathology, Faculty of Medicine and Health Sciences, University of Auckland, Auckland, New Zealand. Dr. Conaghan has been a speaker or on advisory boards for BMS, Janssen, Merck, Pfizer, and Roche. F. Gandjbakhch, MD, Practicing Rheumatologist, Department of Rheumatology, Pitie Salpetriere Hospital, APHP, Université Paris 6-UPMC; E.A. Haavardsholm, MD, PhD, Postdoctoral Researcher, Department of Rheumatology, Diakonhjemmet Hospital; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Professor of Musculoskeletal Medicine, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit; B. Ejbjerg, MD, PhD, Consultant Rheumatologist, Department of Rheumatology, Slagelse Hospital; V. Foltz, MD, Practicing Rheumatologist, Department of Rheumatology, Pitie Salpetriere Hospital, APHP, Université Paris 6-UPMC; A.K. Brown, MB, ChB, MRCP, PhD, Hull York Medical School, University of York; U.M. Døhn, MD, PhD, Senior/Registrar, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Glostrup; M. Lassere, MBBS(Hons), PhD, Grad Dip Epi, FRACP, FAFPHM, Professor of Medicine, St. George Hospital, University of NSW; J.E. Freeston, MA, MD, MRCP, Senior Lecturer and Honorary Consultant Rheumatologist, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit; I.C. Olsen, PhD, Biostatistician, Department of Rheumatology, Diakonhjemmet Hospital; P. Bøyesen, MD, PhD, Senior Registrar, Department of Rheumatology, Diakonhjemmet Hospital; P. Bird, BMed (Hons), FRACP, PhD, Grad Dip MRI, Senior Lecturer, University of NSW; B. Fautrel, MD, PhD, Associate Professor in Medicine, Department of Rheumatology, Pitie Salpetriere Hospital, APHP, Université Paris 6-UPMC; M.L. Hetland, MD, PhD, DMSc, Consultant and Senior Lecturer in Rheumatology, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Glostrup Hospital, and Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen; P. Emery, MA, MD, FRCP, ARC Professor in Rheumatology, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit. Drs. Gandjbakhch and Haavardsholm contributed equally to this work. Address correspondence to Dr. Haavardsholm, Diakonhjemmet Hospital, Box 23 Vindern, 0319 Oslo, Norway; E-mail: e.a.haavardsholm@medisin.uio.no.
Merete Lund Hetland
From the Department of Rheumatology, Pitie Salpetriere Hospital, APHP, Université Paris 6-UPMC, Paris, France; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Department of Rheumatology, Slagelse Hospital, Slagelse, Denmark; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Hull York Medical School, University of York, York, UK; Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Glostrup Hospital, Copenhagen, Denmark; and Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; St. George Hospital, University of NSW, Sydney, Australia; King Christian X’s Hospital for Rheumatic Diseases, University of Southern Denmark, Odense, Denmark; and Department of Molecular Medicine and Pathology, Faculty of Medicine and Health Sciences, University of Auckland, Auckland, New Zealand. Dr. Conaghan has been a speaker or on advisory boards for BMS, Janssen, Merck, Pfizer, and Roche. F. Gandjbakhch, MD, Practicing Rheumatologist, Department of Rheumatology, Pitie Salpetriere Hospital, APHP, Université Paris 6-UPMC; E.A. Haavardsholm, MD, PhD, Postdoctoral Researcher, Department of Rheumatology, Diakonhjemmet Hospital; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Professor of Musculoskeletal Medicine, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit; B. Ejbjerg, MD, PhD, Consultant Rheumatologist, Department of Rheumatology, Slagelse Hospital; V. Foltz, MD, Practicing Rheumatologist, Department of Rheumatology, Pitie Salpetriere Hospital, APHP, Université Paris 6-UPMC; A.K. Brown, MB, ChB, MRCP, PhD, Hull York Medical School, University of York; U.M. Døhn, MD, PhD, Senior/Registrar, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Glostrup; M. Lassere, MBBS(Hons), PhD, Grad Dip Epi, FRACP, FAFPHM, Professor of Medicine, St. George Hospital, University of NSW; J.E. Freeston, MA, MD, MRCP, Senior Lecturer and Honorary Consultant Rheumatologist, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit; I.C. Olsen, PhD, Biostatistician, Department of Rheumatology, Diakonhjemmet Hospital; P. Bøyesen, MD, PhD, Senior Registrar, Department of Rheumatology, Diakonhjemmet Hospital; P. Bird, BMed (Hons), FRACP, PhD, Grad Dip MRI, Senior Lecturer, University of NSW; B. Fautrel, MD, PhD, Associate Professor in Medicine, Department of Rheumatology, Pitie Salpetriere Hospital, APHP, Université Paris 6-UPMC; M.L. Hetland, MD, PhD, DMSc, Consultant and Senior Lecturer in Rheumatology, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Glostrup Hospital, and Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen; P. Emery, MA, MD, FRCP, ARC Professor in Rheumatology, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit. Drs. Gandjbakhch and Haavardsholm contributed equally to this work. Address correspondence to Dr. Haavardsholm, Diakonhjemmet Hospital, Box 23 Vindern, 0319 Oslo, Norway; E-mail: e.a.haavardsholm@medisin.uio.no.
Paul Emery
From the Department of Rheumatology, Pitie Salpetriere Hospital, APHP, Université Paris 6-UPMC, Paris, France; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Department of Rheumatology, Slagelse Hospital, Slagelse, Denmark; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Hull York Medical School, University of York, York, UK; Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Glostrup Hospital, Copenhagen, Denmark; and Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; St. George Hospital, University of NSW, Sydney, Australia; King Christian X’s Hospital for Rheumatic Diseases, University of Southern Denmark, Odense, Denmark; and Department of Molecular Medicine and Pathology, Faculty of Medicine and Health Sciences, University of Auckland, Auckland, New Zealand. Dr. Conaghan has been a speaker or on advisory boards for BMS, Janssen, Merck, Pfizer, and Roche. F. Gandjbakhch, MD, Practicing Rheumatologist, Department of Rheumatology, Pitie Salpetriere Hospital, APHP, Université Paris 6-UPMC; E.A. Haavardsholm, MD, PhD, Postdoctoral Researcher, Department of Rheumatology, Diakonhjemmet Hospital; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Professor of Musculoskeletal Medicine, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit; B. Ejbjerg, MD, PhD, Consultant Rheumatologist, Department of Rheumatology, Slagelse Hospital; V. Foltz, MD, Practicing Rheumatologist, Department of Rheumatology, Pitie Salpetriere Hospital, APHP, Université Paris 6-UPMC; A.K. Brown, MB, ChB, MRCP, PhD, Hull York Medical School, University of York; U.M. Døhn, MD, PhD, Senior/Registrar, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Glostrup; M. Lassere, MBBS(Hons), PhD, Grad Dip Epi, FRACP, FAFPHM, Professor of Medicine, St. George Hospital, University of NSW; J.E. Freeston, MA, MD, MRCP, Senior Lecturer and Honorary Consultant Rheumatologist, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit; I.C. Olsen, PhD, Biostatistician, Department of Rheumatology, Diakonhjemmet Hospital; P. Bøyesen, MD, PhD, Senior Registrar, Department of Rheumatology, Diakonhjemmet Hospital; P. Bird, BMed (Hons), FRACP, PhD, Grad Dip MRI, Senior Lecturer, University of NSW; B. Fautrel, MD, PhD, Associate Professor in Medicine, Department of Rheumatology, Pitie Salpetriere Hospital, APHP, Université Paris 6-UPMC; M.L. Hetland, MD, PhD, DMSc, Consultant and Senior Lecturer in Rheumatology, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Glostrup Hospital, and Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen; P. Emery, MA, MD, FRCP, ARC Professor in Rheumatology, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit. Drs. Gandjbakhch and Haavardsholm contributed equally to this work. Address correspondence to Dr. Haavardsholm, Diakonhjemmet Hospital, Box 23 Vindern, 0319 Oslo, Norway; E-mail: e.a.haavardsholm@medisin.uio.no.
Pierre Bourgeois
From the Department of Rheumatology, Pitie Salpetriere Hospital, APHP, Université Paris 6-UPMC, Paris, France; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Department of Rheumatology, Slagelse Hospital, Slagelse, Denmark; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Hull York Medical School, University of York, York, UK; Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Glostrup Hospital, Copenhagen, Denmark; and Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; St. George Hospital, University of NSW, Sydney, Australia; King Christian X’s Hospital for Rheumatic Diseases, University of Southern Denmark, Odense, Denmark; and Department of Molecular Medicine and Pathology, Faculty of Medicine and Health Sciences, University of Auckland, Auckland, New Zealand. Dr. Conaghan has been a speaker or on advisory boards for BMS, Janssen, Merck, Pfizer, and Roche. F. Gandjbakhch, MD, Practicing Rheumatologist, Department of Rheumatology, Pitie Salpetriere Hospital, APHP, Université Paris 6-UPMC; E.A. Haavardsholm, MD, PhD, Postdoctoral Researcher, Department of Rheumatology, Diakonhjemmet Hospital; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Professor of Musculoskeletal Medicine, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit; B. Ejbjerg, MD, PhD, Consultant Rheumatologist, Department of Rheumatology, Slagelse Hospital; V. Foltz, MD, Practicing Rheumatologist, Department of Rheumatology, Pitie Salpetriere Hospital, APHP, Université Paris 6-UPMC; A.K. Brown, MB, ChB, MRCP, PhD, Hull York Medical School, University of York; U.M. Døhn, MD, PhD, Senior/Registrar, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Glostrup; M. Lassere, MBBS(Hons), PhD, Grad Dip Epi, FRACP, FAFPHM, Professor of Medicine, St. George Hospital, University of NSW; J.E. Freeston, MA, MD, MRCP, Senior Lecturer and Honorary Consultant Rheumatologist, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit; I.C. Olsen, PhD, Biostatistician, Department of Rheumatology, Diakonhjemmet Hospital; P. Bøyesen, MD, PhD, Senior Registrar, Department of Rheumatology, Diakonhjemmet Hospital; P. Bird, BMed (Hons), FRACP, PhD, Grad Dip MRI, Senior Lecturer, University of NSW; B. Fautrel, MD, PhD, Associate Professor in Medicine, Department of Rheumatology, Pitie Salpetriere Hospital, APHP, Université Paris 6-UPMC; M.L. Hetland, MD, PhD, DMSc, Consultant and Senior Lecturer in Rheumatology, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Glostrup Hospital, and Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen; P. Emery, MA, MD, FRCP, ARC Professor in Rheumatology, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit. Drs. Gandjbakhch and Haavardsholm contributed equally to this work. Address correspondence to Dr. Haavardsholm, Diakonhjemmet Hospital, Box 23 Vindern, 0319 Oslo, Norway; E-mail: e.a.haavardsholm@medisin.uio.no.
Kim Hørslev-Petersen
From the Department of Rheumatology, Pitie Salpetriere Hospital, APHP, Université Paris 6-UPMC, Paris, France; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Department of Rheumatology, Slagelse Hospital, Slagelse, Denmark; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Hull York Medical School, University of York, York, UK; Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Glostrup Hospital, Copenhagen, Denmark; and Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; St. George Hospital, University of NSW, Sydney, Australia; King Christian X’s Hospital for Rheumatic Diseases, University of Southern Denmark, Odense, Denmark; and Department of Molecular Medicine and Pathology, Faculty of Medicine and Health Sciences, University of Auckland, Auckland, New Zealand. Dr. Conaghan has been a speaker or on advisory boards for BMS, Janssen, Merck, Pfizer, and Roche. F. Gandjbakhch, MD, Practicing Rheumatologist, Department of Rheumatology, Pitie Salpetriere Hospital, APHP, Université Paris 6-UPMC; E.A. Haavardsholm, MD, PhD, Postdoctoral Researcher, Department of Rheumatology, Diakonhjemmet Hospital; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Professor of Musculoskeletal Medicine, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit; B. Ejbjerg, MD, PhD, Consultant Rheumatologist, Department of Rheumatology, Slagelse Hospital; V. Foltz, MD, Practicing Rheumatologist, Department of Rheumatology, Pitie Salpetriere Hospital, APHP, Université Paris 6-UPMC; A.K. Brown, MB, ChB, MRCP, PhD, Hull York Medical School, University of York; U.M. Døhn, MD, PhD, Senior/Registrar, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Glostrup; M. Lassere, MBBS(Hons), PhD, Grad Dip Epi, FRACP, FAFPHM, Professor of Medicine, St. George Hospital, University of NSW; J.E. Freeston, MA, MD, MRCP, Senior Lecturer and Honorary Consultant Rheumatologist, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit; I.C. Olsen, PhD, Biostatistician, Department of Rheumatology, Diakonhjemmet Hospital; P. Bøyesen, MD, PhD, Senior Registrar, Department of Rheumatology, Diakonhjemmet Hospital; P. Bird, BMed (Hons), FRACP, PhD, Grad Dip MRI, Senior Lecturer, University of NSW; B. Fautrel, MD, PhD, Associate Professor in Medicine, Department of Rheumatology, Pitie Salpetriere Hospital, APHP, Université Paris 6-UPMC; M.L. Hetland, MD, PhD, DMSc, Consultant and Senior Lecturer in Rheumatology, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Glostrup Hospital, and Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen; P. Emery, MA, MD, FRCP, ARC Professor in Rheumatology, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit. Drs. Gandjbakhch and Haavardsholm contributed equally to this work. Address correspondence to Dr. Haavardsholm, Diakonhjemmet Hospital, Box 23 Vindern, 0319 Oslo, Norway; E-mail: e.a.haavardsholm@medisin.uio.no.
Tore K. Kvien
From the Department of Rheumatology, Pitie Salpetriere Hospital, APHP, Université Paris 6-UPMC, Paris, France; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Department of Rheumatology, Slagelse Hospital, Slagelse, Denmark; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Hull York Medical School, University of York, York, UK; Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Glostrup Hospital, Copenhagen, Denmark; and Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; St. George Hospital, University of NSW, Sydney, Australia; King Christian X’s Hospital for Rheumatic Diseases, University of Southern Denmark, Odense, Denmark; and Department of Molecular Medicine and Pathology, Faculty of Medicine and Health Sciences, University of Auckland, Auckland, New Zealand. Dr. Conaghan has been a speaker or on advisory boards for BMS, Janssen, Merck, Pfizer, and Roche. F. Gandjbakhch, MD, Practicing Rheumatologist, Department of Rheumatology, Pitie Salpetriere Hospital, APHP, Université Paris 6-UPMC; E.A. Haavardsholm, MD, PhD, Postdoctoral Researcher, Department of Rheumatology, Diakonhjemmet Hospital; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Professor of Musculoskeletal Medicine, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit; B. Ejbjerg, MD, PhD, Consultant Rheumatologist, Department of Rheumatology, Slagelse Hospital; V. Foltz, MD, Practicing Rheumatologist, Department of Rheumatology, Pitie Salpetriere Hospital, APHP, Université Paris 6-UPMC; A.K. Brown, MB, ChB, MRCP, PhD, Hull York Medical School, University of York; U.M. Døhn, MD, PhD, Senior/Registrar, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Glostrup; M. Lassere, MBBS(Hons), PhD, Grad Dip Epi, FRACP, FAFPHM, Professor of Medicine, St. George Hospital, University of NSW; J.E. Freeston, MA, MD, MRCP, Senior Lecturer and Honorary Consultant Rheumatologist, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit; I.C. Olsen, PhD, Biostatistician, Department of Rheumatology, Diakonhjemmet Hospital; P. Bøyesen, MD, PhD, Senior Registrar, Department of Rheumatology, Diakonhjemmet Hospital; P. Bird, BMed (Hons), FRACP, PhD, Grad Dip MRI, Senior Lecturer, University of NSW; B. Fautrel, MD, PhD, Associate Professor in Medicine, Department of Rheumatology, Pitie Salpetriere Hospital, APHP, Université Paris 6-UPMC; M.L. Hetland, MD, PhD, DMSc, Consultant and Senior Lecturer in Rheumatology, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Glostrup Hospital, and Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen; P. Emery, MA, MD, FRCP, ARC Professor in Rheumatology, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit. Drs. Gandjbakhch and Haavardsholm contributed equally to this work. Address correspondence to Dr. Haavardsholm, Diakonhjemmet Hospital, Box 23 Vindern, 0319 Oslo, Norway; E-mail: e.a.haavardsholm@medisin.uio.no.
Fiona M. McQueen
From the Department of Rheumatology, Pitie Salpetriere Hospital, APHP, Université Paris 6-UPMC, Paris, France; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Department of Rheumatology, Slagelse Hospital, Slagelse, Denmark; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Hull York Medical School, University of York, York, UK; Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Glostrup Hospital, Copenhagen, Denmark; and Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; St. George Hospital, University of NSW, Sydney, Australia; King Christian X’s Hospital for Rheumatic Diseases, University of Southern Denmark, Odense, Denmark; and Department of Molecular Medicine and Pathology, Faculty of Medicine and Health Sciences, University of Auckland, Auckland, New Zealand. Dr. Conaghan has been a speaker or on advisory boards for BMS, Janssen, Merck, Pfizer, and Roche. F. Gandjbakhch, MD, Practicing Rheumatologist, Department of Rheumatology, Pitie Salpetriere Hospital, APHP, Université Paris 6-UPMC; E.A. Haavardsholm, MD, PhD, Postdoctoral Researcher, Department of Rheumatology, Diakonhjemmet Hospital; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Professor of Musculoskeletal Medicine, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit; B. Ejbjerg, MD, PhD, Consultant Rheumatologist, Department of Rheumatology, Slagelse Hospital; V. Foltz, MD, Practicing Rheumatologist, Department of Rheumatology, Pitie Salpetriere Hospital, APHP, Université Paris 6-UPMC; A.K. Brown, MB, ChB, MRCP, PhD, Hull York Medical School, University of York; U.M. Døhn, MD, PhD, Senior/Registrar, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Glostrup; M. Lassere, MBBS(Hons), PhD, Grad Dip Epi, FRACP, FAFPHM, Professor of Medicine, St. George Hospital, University of NSW; J.E. Freeston, MA, MD, MRCP, Senior Lecturer and Honorary Consultant Rheumatologist, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit; I.C. Olsen, PhD, Biostatistician, Department of Rheumatology, Diakonhjemmet Hospital; P. Bøyesen, MD, PhD, Senior Registrar, Department of Rheumatology, Diakonhjemmet Hospital; P. Bird, BMed (Hons), FRACP, PhD, Grad Dip MRI, Senior Lecturer, University of NSW; B. Fautrel, MD, PhD, Associate Professor in Medicine, Department of Rheumatology, Pitie Salpetriere Hospital, APHP, Université Paris 6-UPMC; M.L. Hetland, MD, PhD, DMSc, Consultant and Senior Lecturer in Rheumatology, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Glostrup Hospital, and Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen; P. Emery, MA, MD, FRCP, ARC Professor in Rheumatology, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit. Drs. Gandjbakhch and Haavardsholm contributed equally to this work. Address correspondence to Dr. Haavardsholm, Diakonhjemmet Hospital, Box 23 Vindern, 0319 Oslo, Norway; E-mail: e.a.haavardsholm@medisin.uio.no.
Mikkel Østergaard
From the Department of Rheumatology, Pitie Salpetriere Hospital, APHP, Université Paris 6-UPMC, Paris, France; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Department of Rheumatology, Slagelse Hospital, Slagelse, Denmark; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Hull York Medical School, University of York, York, UK; Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Glostrup Hospital, Copenhagen, Denmark; and Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; St. George Hospital, University of NSW, Sydney, Australia; King Christian X’s Hospital for Rheumatic Diseases, University of Southern Denmark, Odense, Denmark; and Department of Molecular Medicine and Pathology, Faculty of Medicine and Health Sciences, University of Auckland, Auckland, New Zealand. Dr. Conaghan has been a speaker or on advisory boards for BMS, Janssen, Merck, Pfizer, and Roche. F. Gandjbakhch, MD, Practicing Rheumatologist, Department of Rheumatology, Pitie Salpetriere Hospital, APHP, Université Paris 6-UPMC; E.A. Haavardsholm, MD, PhD, Postdoctoral Researcher, Department of Rheumatology, Diakonhjemmet Hospital; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Professor of Musculoskeletal Medicine, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit; B. Ejbjerg, MD, PhD, Consultant Rheumatologist, Department of Rheumatology, Slagelse Hospital; V. Foltz, MD, Practicing Rheumatologist, Department of Rheumatology, Pitie Salpetriere Hospital, APHP, Université Paris 6-UPMC; A.K. Brown, MB, ChB, MRCP, PhD, Hull York Medical School, University of York; U.M. Døhn, MD, PhD, Senior/Registrar, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Glostrup; M. Lassere, MBBS(Hons), PhD, Grad Dip Epi, FRACP, FAFPHM, Professor of Medicine, St. George Hospital, University of NSW; J.E. Freeston, MA, MD, MRCP, Senior Lecturer and Honorary Consultant Rheumatologist, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit; I.C. Olsen, PhD, Biostatistician, Department of Rheumatology, Diakonhjemmet Hospital; P. Bøyesen, MD, PhD, Senior Registrar, Department of Rheumatology, Diakonhjemmet Hospital; P. Bird, BMed (Hons), FRACP, PhD, Grad Dip MRI, Senior Lecturer, University of NSW; B. Fautrel, MD, PhD, Associate Professor in Medicine, Department of Rheumatology, Pitie Salpetriere Hospital, APHP, Université Paris 6-UPMC; M.L. Hetland, MD, PhD, DMSc, Consultant and Senior Lecturer in Rheumatology, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Glostrup Hospital, and Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen; P. Emery, MA, MD, FRCP, ARC Professor in Rheumatology, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit. Drs. Gandjbakhch and Haavardsholm contributed equally to this work. Address correspondence to Dr. Haavardsholm, Diakonhjemmet Hospital, Box 23 Vindern, 0319 Oslo, Norway; E-mail: e.a.haavardsholm@medisin.uio.no.
Article Information
jrheum.131088
PubMed
Published By
Print ISSN
Online ISSN
History
- Published online December 15, 2013.
Article Versions
- You are currently viewing a Latest version of this article (December 15, 2013 - 04:00).
- View the most recent version of this article
Copyright & Usage
© 2013 The Journal of Rheumatology
Author Information
- Frédérique Gandjbakhch,
- Espen A. Haavardsholm,
- Philip G. Conaghan,
- Bo Ejbjerg,
- Violaine Foltz,
- Andrew K. Brown,
- Uffe Møller Døhn,
- Marissa Lassere,
- Jane E. Freeston,
- Inge Christoffer Olsen,
- Pernille Bøyesen,
- Paul Bird,
- Bruno Fautrel,
- Merete Lund Hetland,
- Paul Emery,
- Pierre Bourgeois,
- Kim Hørslev-Petersen,
- Tore K. Kvien,
- Fiona M. McQueen and
- Mikkel Østergaard
- From the Department of Rheumatology, Pitie Salpetriere Hospital, APHP, Université Paris 6-UPMC, Paris, France; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Department of Rheumatology, Slagelse Hospital, Slagelse, Denmark; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Hull York Medical School, University of York, York, UK; Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Glostrup Hospital, Copenhagen, Denmark; and Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; St. George Hospital, University of NSW, Sydney, Australia; King Christian X’s Hospital for Rheumatic Diseases, University of Southern Denmark, Odense, Denmark; and Department of Molecular Medicine and Pathology, Faculty of Medicine and Health Sciences, University of Auckland, Auckland, New Zealand.
Dr. Conaghan has been a speaker or on advisory boards for BMS, Janssen, Merck, Pfizer, and Roche.
F. Gandjbakhch, MD, Practicing Rheumatologist, Department of Rheumatology, Pitie Salpetriere Hospital, APHP, Université Paris 6-UPMC; E.A. Haavardsholm, MD, PhD, Postdoctoral Researcher, Department of Rheumatology, Diakonhjemmet Hospital; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Professor of Musculoskeletal Medicine, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit; B. Ejbjerg, MD, PhD, Consultant Rheumatologist, Department of Rheumatology, Slagelse Hospital; V. Foltz, MD, Practicing Rheumatologist, Department of Rheumatology, Pitie Salpetriere Hospital, APHP, Université Paris 6-UPMC; A.K. Brown, MB, ChB, MRCP, PhD, Hull York Medical School, University of York; U.M. Døhn, MD, PhD, Senior/Registrar, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Glostrup; M. Lassere, MBBS(Hons), PhD, Grad Dip Epi, FRACP, FAFPHM, Professor of Medicine, St. George Hospital, University of NSW; J.E. Freeston, MA, MD, MRCP, Senior Lecturer and Honorary Consultant Rheumatologist, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit; I.C. Olsen, PhD, Biostatistician, Department of Rheumatology, Diakonhjemmet Hospital; P. Bøyesen, MD, PhD, Senior Registrar, Department of Rheumatology, Diakonhjemmet Hospital; P. Bird, BMed (Hons), FRACP, PhD, Grad Dip MRI, Senior Lecturer, University of NSW; B. Fautrel, MD, PhD, Associate Professor in Medicine, Department of Rheumatology, Pitie Salpetriere Hospital, APHP, Université Paris 6-UPMC; M.L. Hetland, MD, PhD, DMSc, Consultant and Senior Lecturer in Rheumatology, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Glostrup Hospital, and Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen; P. Emery, MA, MD, FRCP, ARC Professor in Rheumatology, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit.
Drs. Gandjbakhch and Haavardsholm contributed equally to this work.
Address correspondence to Dr. Haavardsholm, Diakonhjemmet Hospital, Box 23 Vindern, 0319 Oslo, Norway; E-mail: e.a.haavardsholm@medisin.uio.no.
Article usage
Statistics from Altmetric.com
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Determining a Magnetic Resonance Imaging Inflammatory Activity Acceptable State Without Subsequent Radiographic Progression in Rheumatoid Arthritis: Results from a Followup MRI Study of 254 Patients in Clinical Remission or Low Disease Activity
Frédérique Gandjbakhch, Espen A. Haavardsholm, Philip G. Conaghan, Bo Ejbjerg, Violaine Foltz, Andrew K. Brown, Uffe Møller Døhn, Marissa Lassere, Jane E. Freeston, Inge Christoffer Olsen, Pernille Bøyesen, Paul Bird, Bruno Fautrel, Merete Lund Hetland, Paul Emery, Pierre Bourgeois, Kim Hørslev-Petersen, Tore K. Kvien, Fiona M. McQueen, Mikkel Østergaard
The Journal of Rheumatology Dec 2013, jrheum.131088; DOI: 10.3899/jrheum.131088
Determining a Magnetic Resonance Imaging Inflammatory Activity Acceptable State Without Subsequent Radiographic Progression in Rheumatoid Arthritis: Results from a Followup MRI Study of 254 Patients in Clinical Remission or Low Disease Activity
Frédérique Gandjbakhch, Espen A. Haavardsholm, Philip G. Conaghan, Bo Ejbjerg, Violaine Foltz, Andrew K. Brown, Uffe Møller Døhn, Marissa Lassere, Jane E. Freeston, Inge Christoffer Olsen, Pernille Bøyesen, Paul Bird, Bruno Fautrel, Merete Lund Hetland, Paul Emery, Pierre Bourgeois, Kim Hørslev-Petersen, Tore K. Kvien, Fiona M. McQueen, Mikkel Østergaard
The Journal of Rheumatology Dec 2013, jrheum.131088; DOI: 10.3899/jrheum.131088